JP2025505142A5 - - Google Patents
Info
- Publication number
- JP2025505142A5 JP2025505142A5 JP2024545809A JP2024545809A JP2025505142A5 JP 2025505142 A5 JP2025505142 A5 JP 2025505142A5 JP 2024545809 A JP2024545809 A JP 2024545809A JP 2024545809 A JP2024545809 A JP 2024545809A JP 2025505142 A5 JP2025505142 A5 JP 2025505142A5
- Authority
- JP
- Japan
- Prior art keywords
- xrpd pattern
- morphology according
- cukα
- crystal morphology
- crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263306781P | 2022-02-04 | 2022-02-04 | |
| US63/306,781 | 2022-02-04 | ||
| PCT/US2023/012252 WO2023150250A1 (en) | 2022-02-04 | 2023-02-03 | Crystalline salt and solvate forms of murizatoclax (amg 397) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025505142A JP2025505142A (ja) | 2025-02-21 |
| JP2025505142A5 true JP2025505142A5 (enExample) | 2026-03-11 |
Family
ID=86054183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024545809A Pending JP2025505142A (ja) | 2022-02-04 | 2023-02-03 | ムリザトクラクス（ａｍｇ３９７）の結晶塩及び溶媒和物形態 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250122224A1 (enExample) |
| EP (1) | EP4472985A1 (enExample) |
| JP (1) | JP2025505142A (enExample) |
| AU (1) | AU2023215171A1 (enExample) |
| CA (1) | CA3248348A1 (enExample) |
| MX (1) | MX2024009650A (enExample) |
| WO (1) | WO2023150250A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4519271A1 (en) | 2022-05-04 | 2025-03-12 | Gilead Sciences, Inc. | Salts and polymorphs of certain mcl-1 inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8576985B2 (en) | 2009-09-01 | 2013-11-05 | Aptuit (West Lafayette) Llc | Methods for indexing solid forms of compounds |
| JP6453507B2 (ja) * | 2017-03-30 | 2019-01-16 | アムジエン・インコーポレーテツド | Ｍｃｌ−１タンパク質を阻害する化合物 |
| JP2021161114A (ja) * | 2020-03-31 | 2021-10-11 | アムジエン・インコーポレーテツド | Ｍｃｌ−１化合物のメチル化 |
-
2023
- 2023-02-03 WO PCT/US2023/012252 patent/WO2023150250A1/en not_active Ceased
- 2023-02-03 US US18/730,353 patent/US20250122224A1/en active Pending
- 2023-02-03 JP JP2024545809A patent/JP2025505142A/ja active Pending
- 2023-02-03 MX MX2024009650A patent/MX2024009650A/es unknown
- 2023-02-03 AU AU2023215171A patent/AU2023215171A1/en active Pending
- 2023-02-03 CA CA3248348A patent/CA3248348A1/en active Pending
- 2023-02-03 EP EP23718377.7A patent/EP4472985A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6810148B2 (ja) | Ｄｕｂの阻害剤としてのシアノピロリジン誘導体 | |
| ES2249884T3 (es) | Derivados del acido indolil-3-glioxilico con efecto antitumoral. | |
| CA2345146C (en) | Cyanophenyl derivative | |
| US8058444B2 (en) | Heterocycle-substituted pyridine derivative's salt or crystal thereof | |
| EP0931077B1 (en) | Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase | |
| EP3492467A1 (en) | Isoquinolinone compound and use thereof in preparation of antiviral drugs | |
| JP2009535340A5 (enExample) | ||
| HK1252449A1 (zh) | 突变的异柠檬酸脱氢酶idh1 r132h的抑制剂 | |
| US11028069B2 (en) | Salt of substituted piperidine compound | |
| WO2016016766A2 (en) | A process for the preparation of isavuconazonium or its salt thereof | |
| JP2025505142A5 (enExample) | ||
| US20210130333A1 (en) | Crystal of benzofuran derivative free base and preparation method | |
| HU198014B (en) | Process for producing antiarithmic sulfonamides and pharmaceutical compositions containing them | |
| CN115702154A (zh) | 一种嘧啶类化合物的盐和晶型及其制备方法 | |
| KR20230141899A (ko) | [(1S)-1-[(2S,4R,5R)-5-(5-아미노-2-옥소-티아졸로[4,5-d]피리미딘-3-일)-4-하이드록시-테트라하이드로퓨란-2-일]프로필]아세테이트의 고체 형태 | |
| JP2025511331A5 (enExample) | ||
| JP2025513774A5 (enExample) | ||
| US8138349B2 (en) | Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate | |
| JP2025505141A5 (enExample) | ||
| EP0641763B1 (en) | Novel quaternary ammonium salts and use thereof as medicine | |
| JP7750535B2 (ja) | 化合物の結晶形態 | |
| TW202440586A (zh) | 口奈啶化合物的固體形式 | |
| KR20200120935A (ko) | 벤조디아제핀 유도체 염산염과 결정형, 이의 제조 방법 및 적용 | |
| IL305788A (en) | A crystalline salt of a multityrosine kinase inhibitor, a method for its preparation and its use | |
| JP2005519934A5 (enExample) |